The eleven-plus (11+) is more than just a test - it’s the gateway to grammar schools and selective secondary schools in ...
Adam Wharton is the subject of our feature interview for the first programme of 2026. When asked why he is often selected as 'data analyst' in our staff selection feature, Wharton said: "They probably ...
The unemployment rate remains low but rose to its highest level since 2021. The federal government released two major economic reports this week, easing a backlog of data pent up by the 43-day ...
Chris Mooney is a Pulitzer Prize-winning journalist and a CNN Climate contributor. He is currently a professor of practice in the Environmental Institute at the University of Virginia. Planet-warming ...
Marvell Technology’s upbeat guidance had Wall Street cheering on Wednesday, but some analysts weren’t quite ready to pronounce a turnaround for the chip company, which has thus far been unable to ...
Almost exactly one year ago, Janux Therapeutics unveiled early data for its investigational T-cell engager that wowed investors and analysts alike. But the biotech’s newest update has failed to garner ...
The UK government’s decision to maintain the Energy Profits Levy through 2030 has been met with disappointment by industry and trade unions, with analysts warning that the fiscal regime will deplete ...
One analyst said Bitcoin’s dip to $80,000 marked the bottom and that there was a 91% chance the current trend reversal would send BTC price back to $118,000. A Bitcoin analyst assigned a 91% ...
Shares of Nvidia (NVDA) dipped about 1% on Thursday despite an "exceptional" quarter and "stellar" guidance. The stock gave up its gains of about 5% premarket, which would have seen the company's ...
Three data center stocks skyrocketed after releasing their latest financial results. However, Wall Street analysts appear concerned about two of these names, while being more optimistic about another.
The Trump administration on Thursday announced a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims to deliver lower prices for their popular GLP-1 drugs to certain Medicare ...
Atishay Jain is the CEO of Zingle AI Lab (AI code reviews for data teams that cut warehouse cost and production incidents). In 2025, major enterprises are racing to deploy AI data assistants—but are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results